Acted on behalf of 35,000 individual shareholders in the RBS Rights Issue Litigation

Author:

Signature Litigation

Signature Litigation has been instructed by the RBoS Shareholders Action Group on behalf of 101 institutional clients and over 35,000 individual shareholders bringing claims against RBS over its 2008 rights issue following the disastrous acquisition of ABN Amro. This case has been recognised as one of The Lawyer’s top 20 cases of 2017.

Latest news

SignatureLitigation
@SignatureLitLLP

Partner Sylvie Gallage-Alwis is moderating the 'MINI SUMMIT 7: How to Build and Manage Healthcare Compliance Risk Assessments' at 10 am today. lnkd.in/evvkhhB #pharmaceutical #medicaldevices #healthcare @PharmaCongress pic.twitter.com/jcd2Sd6nCh

About 6 days ago from Signature Litigation's Twitter via Twitter Web App

Partner @florepoloni and Associate Thibaud Roujou de Boubée examine how #arbitration is particularly suited to disputes relating to #newtechnologies, in @usinenouvelle bit.ly/3fXcOW0 pic.twitter.com/Y6jHwZgKlc

About 2 weeks ago from Signature Litigation's Twitter via Twitter Web App

Counsel Neil Newing will be speaking at the Global TransPerfect @GLNXT EU user conference as part of a panel discussing ‘managing multi-language litigation’ bit.ly/3pqPhjs pic.twitter.com/q7yxMpWEKL

About 2 weeks ago from Signature Litigation's Twitter via Twitter Web App

Partner Thomas Rouhette has been interviewed in @predictice, on his motivation to building #SignatureLitigation Paris and the challenges he overcame. bit.ly/2TDzTEG pic.twitter.com/HDklCMrt34

About 2 weeks ago from Signature Litigation's Twitter via Twitter Web App

Partner Thomas Rouhette and senior associate Claire Massiera recently co-authored a chapter in Private Enforcement of Competition Law in Europe, published by @LarcierGrp bit.ly/3g3RLQB pic.twitter.com/4bpffPRl4w

About 2 weeks ago from Signature Litigation's Twitter via Twitter Web App

Signature Litigation is excited to be one of the sponsors for this year’s International Pharmaceutical and Medical Devices E&E Congress

15 June 2021

L’affaire SORELEC : l’absence d’allégations de corruption doit susciter la méfiance des arbitres – Flore Poloni et Nicolas Brooke

8 June 2021

Quatre raisons de privilégier l’arbitrage dans les litiges sur de nouvelles technologies – Flore Poloni et Thibaud Roujou de Boubée

7 June 2021

CNIL – publication de son rapport annuel d’activité 2020

18 June 2021

Signature Litigation is excited to be one of the sponsors for this year’s International Pharmaceutical and Medical Devices E&E Congress

15 June 2021

International Arbitration Update – 2020 Statistics

14 June 2021

All news

All Services


Antitrust	Banking and Financial Markets Litigation	Contentious Trusts, Estates and Private Wealth Litigation
Energy and Infrastructure Disputes	Insurance and Reinsurance Litigation	Judicial Review and Regulatory Disputes
Professional Negligence Litigation	Russia and CIS Disputes	Toxic Tort Litigation
White Collar Crime and Regulatory Investigations

Key Services

All Services

News